Cancer therapy utilizing an adenoviral vector expressing only E1A

Cancer Gene Therapy

Volumn 9, Issue 4, 2002, Pages 321-329

  Hubberstey, Andrew V ^a   Pavliv, Marta ^b   Parks, Robin J ^b,c  

^a UNIVERSITY OF WINDSOR   (Canada)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Adenovirus; Cancer; E1A; Gene therapy

Indexed keywords

ADENOVIRUS VECTOR; AGAROSE; BETA GALACTOSIDASE; CISPLATIN; VIRUS PROTEIN;

ADENOVIRUS 5; ADHERENT CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER THERAPY; CARCINOGENESIS; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; CULTURE MEDIUM; DRUG POTENTIATION; DRUG SENSITIVITY; GENE TARGETING; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ADENOVIRIDAE; ADENOVIRUS E1A PROTEINS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CELL DIVISION; CISPLATIN; DEFECTIVE VIRUSES; DRUG RESISTANCE, NEOPLASM; DRUG SYNERGISM; GENE THERAPY; GENES, VIRAL; GENETIC VECTORS; HUMANS; IMMUNOENZYME TECHNIQUES; LUNG NEOPLASMS; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY;

ADENOVIRIDAE; ANIMALIA; HUMAN ADENOVIRUS; HUMAN ADENOVIRUS TYPE 5;

EID: 0036215242     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700436     Document Type: Article

References (53)

1. Adenoviridae the viruses and their replication
2. Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells
3. Enhanced expression of p53 in human cells infected with mutant adenoviruses
4. Adenoviral E1A-associated protein p300 as a functional homologue of the transcriptional co-activator CBP
5. A family of transcriptional adaptor proteins targeted by the E1A oncoprotein
6. E1A directly binds and regulates the P/CAF acetyltransferase
7. A region in the C-terminus of adenovirus 2/5 E1A protein is required for association with a cellular phosphoprotein and important for the negative modulation of T24-ras mediated transformation, tumorigenesis and metastasis
8. Detection of cellular proteins associated with human adenovirus type 5 early region 1A polypeptides
9. Human cyclin A and the retinoblastoma protein interact with similar but distinguishable sequences in the adenovirus E1A gene product
10. Association of adenovirus early-region 1A proteins with cellular polypeptides
11. Tumour suppressive properties of the adenovirus 5 E1A oncogene
12. Tumor suppression activity of adenovirus E1A protein: Anoikis and the epithelial phenotype
13. Adenovirus E1A-mediated tumor suppression by a c-erbB-2/neu-independent mechanism
14. Antioncogenic effect of adenovirus E1A in human tumor cells
15. Adenovirus E1A represses protease gene expression and inhibits metastasis of human tumor cells
16. Carcinoma cell lines become sensitive to DNA-damaging agents by the expression of the adenovirus E1A gene
17. E1A sensitizes cells to tumor necrosis factor-induced apoptosis through inhibition of IkappaB kinases and nuclear factor kappaB activities
18. Chemosensitization of HER-2/neu-overexpressing human breast cancer cells to paclitaxel (Taxol) by adenovirus type 5 E1A
19. Inhibition of nuclear factor-kappaB activity is involved in E1A-mediated sensitization of radiation-induced apoptosis
20. Modulation of cellular susceptibility to the cytotoxic/cytostatic action of tumor necrosis factor by adenovirus E1 gene expression is cell type-dependent
21. Induction by E1A oncogene expression of cellular susceptibility to lysis by TNF
22. E1A overcomes the apoptosis block in BCR-ABL+ leukemia cells and renders cells susceptible to induction of apoptosis by chemotherapeutic agents
23. E1A sensitizes HER2/neu-overexpressing Ewing's sarcoma cells to topoisomerase II-targeting anticancer drugs
24. Inhibition of angiogenesis and induction of apoptosis are involved in E1A-mediated bystander effect and tumor suppression
25. Summary. Human gene marker/therapy clinical protocols (complete updated listings)
26. Phase I trial of intratumoral liposome E1A gene therapy in patients with recurrent breast and head and neck cancer
27. A helper-dependent adenovirus vector system: Removal of helper virus by Cre-mediated excision of the viral packaging signal
28. Peripheral infection with adenovirus causes unexpected long-term brain inflammation in animals injected intracranially with first-generation, but not with high-capacity, adenovirus vectors: Toward realistic long-term neurological gene therapy for chronic diseases
29. High doses of a helper-dependent adenoviral vector yield supraphysiological levels of alpha1-antitrypsin with negligible toxicity
30. Toxicity associated with repeated administration of first-generation adenovirus vectors does not occur with a helper-dependent vector
31. Characteristics of a human cell line transformed by DNA from human adenovirus type 5
32. Techniques for human adenovirus vector construction and characterization
33. Production and characterization of human 293 cell lines expressing the site-specific recombinase Cre
34. A helper-dependent system for adenovirus vector production helps define a lower limit for efficient DNA packaging
35. Effects of stuffer DNA on transgene expression from helper-dependent adenovirus vectors
36. Adenovirus 5 E1A-mediated tumor suppression associated with E1A-mediated apoptosis in vivo
37. An adenovirus mutant that replicates selectively in p53-deficient human tumor cells
38. Does the antitumor adenovirus ONYX-015/d11520 selectively target cells defective in the p53 pathway?
39. Is cisplatin-induced cell death always produced by apoptosis?
40. Lack of correlation between p53 protein level and sensitivity of DNA-damaging agents in keratinocytes carrying adenovirus E1A mutants
41. Functional complementation of the adenovirus E1B 19-kilodalton protein with Bcl-2 in the inhibition of apoptosis in infected cells
42. E1A is sufficient by itself to induce apoptosis independent of p53 and other adenoviral gene products
43. E1A signaling to p53 involves the p19(ARF) tumor suppressor
44. TNF- and cancer therapy - Induced apoptosis: Potentiation by inhibition of NF-kappaB
45. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death
46. An essential role for NF-kappaB in preventing TNF-alpha - Induced cell death
47. Suppression of TNF-alpha - Induced apoptosis by NF-kappaB
48. Adenovirus-2 E1A products repress enhancer-induced stimulation of transcription
49. The tumor suppression activity of E1A in HER-2/neu - Overexpressing breast cancer
50. Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity
51. Adenovirus-mediated regulable target gene expression in vivo
52. Liver-specific alpha 2 interferon gene expression results in protection from induced hepatitis
53. Improved safety through tamoxifen-regulated induction of cytotoxic genes delivered by Ad vectors for cancer gene therapy